# Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

> **NCT00003443** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** bryostatin 1

## Key facts

- **NCT ID:** NCT00003443
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** 2001-05
- **Final completion:** 2001-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003443, "Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00003443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*